Skip to main content
OpenTrials

Clinical trial condition

Macular Degeneration

Explore clinical trials studying Macular Degeneration. Study availability and eligibility vary by location and protocol.

853 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Macular Degeneration trial results

Completed

Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration

NCT01653184

Conditions
Eye Diseases, Macular Degeneration, Nervous System Diseases, +7 more
Locations
  • Mid Atlantic Retina- Cherry Hill Cherry Hill, New Jersey, United States
  • Mid Atlantic Retina - Bethlehem Bethlehem, Pennsylvania, United States
  • Mid Atlantic Retina- Hungtindon Valley Huntingdon Valley, Pennsylvania, United States
  • Mid Atlantic Retina- Wills Eye Institute Philadelphia, Pennsylvania, United States
View Trial Details
Completed

HELP Therapy for Dry AMD

NCT01840683

Conditions
Eye Diseases, Macular Degeneration, Non-exudative (Dry) Age-related Macular Degeneration (AMD), +2 more
Locations
  • Canadian Centre for Advanced Eye Therapeutics Inc. Mississauga, Ontario, Canada
View Trial Details
Completed

EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

NCT00470678

Conditions
Age-Related Macular Degeneration, Choroid Diseases, Choroidal Neovascularization, +9 more
Locations
  • Novartis Investigative Site Daegu, South Korea
  • Novartis Investigative Site Pusan, South Korea
  • Novartis Investigative site Seoul, South Korea
  • Novartis Investigative Site Kaohsiung City, Taiwan
View Trial Details
Completed

Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients

NCT00826371

Conditions
Age Related Macular Degeneration, Eye Diseases, Macular Degeneration, +2 more
Locations
  • Novartis Investigative Site Beijing, China
  • Novartis Investigative Site Beijing, China
  • Novartis Investigational Site Chengdu, China
  • Novartis Investigative Site Guangzhou, China
View Trial Details

Related conditions